Aptevo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aptevo Therapeutics

10/08/2023 15:19

* Aptevo Therapeutics Inc  APVO.OQ  reported a quarterly
adjusted
loss of $1.23​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $1.12
per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aptevo Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.23​.
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aptevo Therapeutics Inc shares had fallen by 65.8% this
quarter and lost 78.4% so far this year.
    * The company reported a quarterly loss of $7.95 million.
    * Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:19 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.12          -1.23          Missed
 Mar. 31 2023      -1.18          0.39           Beat
 Dec. 31 2022      -1.53          -0.95          Beat
 Sep. 30 2022      -1.64          -1.50          Beat